SG Americas Securities LLC Sells 11,880 Shares of STERIS plc $STE

SG Americas Securities LLC cut its stake in shares of STERIS plc (NYSE:STE) by 88.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,481 shares of the medical equipment provider’s stock after selling 11,880 shares during the quarter. SG Americas Securities LLC’s holdings in STERIS were worth $366,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also bought and sold shares of the company. Norges Bank purchased a new position in shares of STERIS in the second quarter worth $289,132,000. Orbis Allan Gray Ltd grew its holdings in STERIS by 36.0% in the 2nd quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock worth $504,486,000 after acquiring an additional 556,088 shares during the last quarter. Invesco Ltd. grew its holdings in STERIS by 32.2% in the 2nd quarter. Invesco Ltd. now owns 1,220,699 shares of the medical equipment provider’s stock worth $293,236,000 after acquiring an additional 297,076 shares during the last quarter. Assenagon Asset Management S.A. increased its position in shares of STERIS by 305.9% in the third quarter. Assenagon Asset Management S.A. now owns 330,907 shares of the medical equipment provider’s stock valued at $81,880,000 after acquiring an additional 249,386 shares during the period. Finally, Qube Research & Technologies Ltd bought a new position in shares of STERIS during the second quarter valued at about $58,402,000. 94.69% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a research note on Friday, January 9th. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $273.50.

STERIS Stock Down 0.6%

STE stock opened at $259.44 on Monday. STERIS plc has a fifty-two week low of $204.90 and a fifty-two week high of $269.44. The business’s 50 day moving average price is $258.84 and its two-hundred day moving average price is $247.68. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.63 and a current ratio of 2.37. The company has a market capitalization of $25.46 billion, a price-to-earnings ratio of 37.28 and a beta of 1.03.

STERIS (NYSE:STE) last released its earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 EPS for the quarter, beating analysts’ consensus estimates of $2.38 by $0.09. STERIS had a return on equity of 14.43% and a net margin of 12.07%.The company had revenue of $1.46 billion during the quarter, compared to analysts’ expectations of $1.43 billion. During the same quarter last year, the business posted $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, analysts forecast that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Stockholders of record on Tuesday, November 18th were issued a dividend of $0.63 per share. This represents a $2.52 annualized dividend and a dividend yield of 1.0%. The ex-dividend date was Tuesday, November 18th. STERIS’s dividend payout ratio (DPR) is presently 36.21%.

Insider Transactions at STERIS

In other STERIS news, VP John Adam Zangerle sold 15,000 shares of the business’s stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $265.14, for a total value of $3,977,100.00. Following the sale, the vice president directly owned 33,669 shares of the company’s stock, valued at approximately $8,926,998.66. The trade was a 30.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Renato Tamaro sold 5,036 shares of the stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $257.55, for a total value of $1,297,021.80. Following the completion of the sale, the vice president directly owned 5,695 shares in the company, valued at approximately $1,466,747.25. This represents a 46.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 25,044 shares of company stock valued at $6,586,218 in the last ninety days. 1.07% of the stock is currently owned by corporate insiders.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.